Angiogenesis is regulated by the activity of endogenous stimulators and inhibitors.
One of the most recent methods that is being developed for the delivery of anti-angiogenesis factors to tumour regions in cancer sufferers is using genetically modified bacteria that are able to colonize solid tumors in vivo.